Skip to main content
. 2024 Feb 8;60(2):287. doi: 10.3390/medicina60020287

Figure 1.

Figure 1

The trend for SANDE severity (mm) (A) and SANDE frequency (mm). (B) * p-value < 0.05 in the comparison between Respilac® and Nextal ophtalmic solutions. SANDE: Symptom assessment questionnaire in dry eye.